Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2022-03-07 02:49:02 UTC |
---|
HMDB ID | HMDB0000430 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | 24,25-Dihydroxyvitamin D |
---|
Description | 24,25-Dihydroxyvitamin D (24R,25(OH)2D3) circulates in blood at concentrations about 1000 times higher than 1alpha,25(OH)2D3. 24-Hydroxylase is present in the proximal convoluted tubule cells of the kidney and in virtual all target cells of 1alpha,25(OH)2D3. Interestingly, 1alpha,25(OH)2D3 is a very strong inducer of 24-hydroxylase activity and 24R,25(OH)2D3 formation. Also parathyroid hormone (PTH) regulates 24-hydroxylase activity but in a tissue specific manner, i.e. inhibitory in the kidney while a synergistic effect together with 1alpha,25(OH)2D3 is observed in osteoblasts. Generally, 24-hydroxylation has been considered the first step in the degradation pathway of 1alpha,25(OH)2D3 and 25-(OH)D3. However, through the past decades data have accumulated that 24R,25(OH)2D3 is not merely a degradation product but has effects on its own. Classic studies have demonstrated the significance of 24R,25(OH)2D3 for normal chicken egg hatchability and calcium and phosphorus homeostasis. More recently it became apparent that 24R,25(OH)2D3 also has distinct effects on cartilage in particular the resting zone cells. 24R,25(OH)2D3 stimulates osteocalcin synthesis in human osteoblasts. 24R,25(OH)2D3 plays a role in bone metabolism but that it acts in concert with 1alpha,25(OH)2D3 to obtain an optimal effect. (PMID: 11179746 ). |
---|
Structure | [H][C@@]12CC[C@H]([C@H](C)CCC(O)C(C)(C)O)[C@@]1(C)CCC\C2=C/C=C1/C[C@H](O)CCC1=C InChI=1S/C27H44O3/c1-18-8-12-22(28)17-21(18)11-10-20-7-6-16-27(5)23(13-14-24(20)27)19(2)9-15-25(29)26(3,4)30/h10-11,19,22-25,28-30H,1,6-9,12-17H2,2-5H3/b20-10+,21-11-/t19-,22-,23-,24+,25?,27-/m1/s1 |
---|
Synonyms | Value | Source |
---|
(3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-3,24,25-triol | HMDB | 24,25-Dihydroxycholecalciferol | HMDB | 24,25-Dihydroxyvitamin | HMDB | 24,25-Dihydroxyvitamin D3 | HMDB | 24-Hydroxycalcidiol | HMDB | Vitamin D | HMDB | 24,25 Dihydroxyvitamin D3 | HMDB | (24R)-24,25-Dihydroxyvitamin D3 | HMDB | 24,25-Dihydroxyvitamin D 3, (3beta,5Z,7E,24R)-isomer | HMDB | 24,25 Dihydroxycholecalciferol | HMDB | Dihydroxyvitamin D3, 24,25 | HMDB | 24R,25-Dihydroxycholecalciferol | HMDB | 24,25 Dihydroxyvitamin D 3 | HMDB | 24,25-Dihydroxyvitamin D 3 | HMDB | 24,25-Dihydroxy-vitamin D | HMDB |
|
---|
Chemical Formula | C27H44O3 |
---|
Average Molecular Weight | 416.6365 |
---|
Monoisotopic Molecular Weight | 416.329045274 |
---|
IUPAC Name | (6R)-6-[(1R,3aS,4E,7aR)-4-{2-[(1Z,5R)-5-hydroxy-2-methylidenecyclohexylidene]ethylidene}-7a-methyl-octahydro-1H-inden-1-yl]-2-methylheptane-2,3-diol |
---|
Traditional Name | 24,25-dihydroxyvitamin |
---|
CAS Registry Number | 40013-87-4 |
---|
SMILES | C[C@H](CCC(O)C(C)(C)O)[C@H]1CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@H](O)CCC1=C |
---|
InChI Identifier | InChI=1S/C27H44O3/c1-18-8-12-22(28)17-21(18)11-10-20-7-6-16-27(5)23(13-14-24(20)27)19(2)9-15-25(29)26(3,4)30/h10-11,19,22-25,28-30H,1,6-9,12-17H2,2-5H3/b20-10+,21-11-/t19-,22-,23-,24+,25?,27-/m1/s1 |
---|
InChI Key | FCKJYANJHNLEEP-OIMXRAFZSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as vitamin d and derivatives. Vitamin D and derivatives are compounds containing a secosteroid backbone, usually secoergostane or secocholestane. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Vitamin D and derivatives |
---|
Direct Parent | Vitamin D and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Triterpenoid
- Tertiary alcohol
- Cyclic alcohol
- Secondary alcohol
- Organic oxygen compound
- Hydrocarbon derivative
- Organooxygen compound
- Alcohol
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times UnderivatizedChromatographic Method | Retention Time | Reference |
---|
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. | 8.41 minutes | 32390414 | Predicted by Siyang on May 30, 2022 | 20.0883 minutes | 33406817 | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.24 minutes | 32390414 | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 3208.0 seconds | 40023050 | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 414.4 seconds | 40023050 | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 244.5 seconds | 40023050 | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 188.7 seconds | 40023050 | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 506.9 seconds | 40023050 | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 948.2 seconds | 40023050 | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 894.0 seconds | 40023050 | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 94.7 seconds | 40023050 | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1681.8 seconds | 40023050 | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 603.1 seconds | 40023050 | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1753.7 seconds | 40023050 | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 604.9 seconds | 40023050 | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 528.2 seconds | 40023050 | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 268.0 seconds | 40023050 | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 554.6 seconds | 40023050 | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 8.7 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
24,25-Dihydroxyvitamin D,1TMS,isomer #1 | C=C1CC[C@@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCC(O[Si](C)(C)C)C(C)(C)O | 3466.2 | Semi standard non polar | 33892256 | 24,25-Dihydroxyvitamin D,1TMS,isomer #2 | C=C1CC[C@@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCC(O)C(C)(C)O[Si](C)(C)C | 3499.0 | Semi standard non polar | 33892256 | 24,25-Dihydroxyvitamin D,1TMS,isomer #3 | C=C1CC[C@@H](O[Si](C)(C)C)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCC(O)C(C)(C)O | 3440.1 | Semi standard non polar | 33892256 | 24,25-Dihydroxyvitamin D,2TMS,isomer #1 | C=C1CC[C@@H](O[Si](C)(C)C)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCC(O[Si](C)(C)C)C(C)(C)O | 3410.9 | Semi standard non polar | 33892256 | 24,25-Dihydroxyvitamin D,2TMS,isomer #2 | C=C1CC[C@@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCC(O[Si](C)(C)C)C(C)(C)O[Si](C)(C)C | 3503.0 | Semi standard non polar | 33892256 | 24,25-Dihydroxyvitamin D,2TMS,isomer #3 | C=C1CC[C@@H](O[Si](C)(C)C)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCC(O)C(C)(C)O[Si](C)(C)C | 3466.2 | Semi standard non polar | 33892256 | 24,25-Dihydroxyvitamin D,3TMS,isomer #1 | C=C1CC[C@@H](O[Si](C)(C)C)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCC(O[Si](C)(C)C)C(C)(C)O[Si](C)(C)C | 3461.8 | Semi standard non polar | 33892256 | 24,25-Dihydroxyvitamin D,1TBDMS,isomer #1 | C=C1CC[C@@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCC(O[Si](C)(C)C(C)(C)C)C(C)(C)O | 3710.0 | Semi standard non polar | 33892256 | 24,25-Dihydroxyvitamin D,1TBDMS,isomer #2 | C=C1CC[C@@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCC(O)C(C)(C)O[Si](C)(C)C(C)(C)C | 3730.6 | Semi standard non polar | 33892256 | 24,25-Dihydroxyvitamin D,1TBDMS,isomer #3 | C=C1CC[C@@H](O[Si](C)(C)C(C)(C)C)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCC(O)C(C)(C)O | 3638.8 | Semi standard non polar | 33892256 | 24,25-Dihydroxyvitamin D,2TBDMS,isomer #1 | C=C1CC[C@@H](O[Si](C)(C)C(C)(C)C)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCC(O[Si](C)(C)C(C)(C)C)C(C)(C)O | 3879.5 | Semi standard non polar | 33892256 | 24,25-Dihydroxyvitamin D,2TBDMS,isomer #2 | C=C1CC[C@@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCC(O[Si](C)(C)C(C)(C)C)C(C)(C)O[Si](C)(C)C(C)(C)C | 3978.0 | Semi standard non polar | 33892256 | 24,25-Dihydroxyvitamin D,2TBDMS,isomer #3 | C=C1CC[C@@H](O[Si](C)(C)C(C)(C)C)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCC(O)C(C)(C)O[Si](C)(C)C(C)(C)C | 3914.5 | Semi standard non polar | 33892256 | 24,25-Dihydroxyvitamin D,3TBDMS,isomer #1 | C=C1CC[C@@H](O[Si](C)(C)C(C)(C)C)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCC(O[Si](C)(C)C(C)(C)C)C(C)(C)O[Si](C)(C)C(C)(C)C | 4179.5 | Semi standard non polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - 24,25-Dihydroxyvitamin D GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a4i-7029200000-c84dd427774a8bd55bf4 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 24,25-Dihydroxyvitamin D GC-MS (3 TMS) - 70eV, Positive | splash10-014i-1312049000-f6115b14a152464f5e1b | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 24,25-Dihydroxyvitamin D GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 24,25-Dihydroxyvitamin D GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 24,25-Dihydroxyvitamin D GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 24,25-Dihydroxyvitamin D GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 24,25-Dihydroxyvitamin D GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 24,25-Dihydroxyvitamin D GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 24,25-Dihydroxyvitamin D GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 24,25-Dihydroxyvitamin D GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 24,25-Dihydroxyvitamin D GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 24,25-Dihydroxyvitamin D GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 24,25-Dihydroxyvitamin D GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 24,25-Dihydroxyvitamin D GC-MS (TBDMS_2_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 24,25-Dihydroxyvitamin D GC-MS (TBDMS_2_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 24,25-Dihydroxyvitamin D GC-MS (TBDMS_3_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 24,25-Dihydroxyvitamin D 10V, Positive-QTOF | splash10-00l2-0119200000-7bcd78fea8093a8230ae | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 24,25-Dihydroxyvitamin D 20V, Positive-QTOF | splash10-0a5a-2369100000-04f3fb5d7d655a9ce470 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 24,25-Dihydroxyvitamin D 40V, Positive-QTOF | splash10-0zgi-4389100000-269c6b355710e7dcd9b8 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 24,25-Dihydroxyvitamin D 10V, Negative-QTOF | splash10-014i-0004900000-7bbe3ea5eae60b2a2059 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 24,25-Dihydroxyvitamin D 20V, Negative-QTOF | splash10-05mk-0009300000-4137913e2e1e7271894c | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 24,25-Dihydroxyvitamin D 40V, Negative-QTOF | splash10-0079-9006000000-b2d6915fde38c349870a | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 24,25-Dihydroxyvitamin D 10V, Positive-QTOF | splash10-00lr-0439300000-d0f3435842264a17a15a | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 24,25-Dihydroxyvitamin D 20V, Positive-QTOF | splash10-00rx-4579100000-2ffe9e7393dd492716a0 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 24,25-Dihydroxyvitamin D 40V, Positive-QTOF | splash10-0avi-2960000000-4329739a1dba4656972b | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 24,25-Dihydroxyvitamin D 10V, Negative-QTOF | splash10-014j-0007900000-764d7cf399a810ff092c | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 24,25-Dihydroxyvitamin D 20V, Negative-QTOF | splash10-0671-3109300000-5c39962acfb73b3f737d | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 24,25-Dihydroxyvitamin D 40V, Negative-QTOF | splash10-01ri-2129300000-7f78982c59e2cf08742c | 2021-09-23 | Wishart Lab | View Spectrum |
|
---|
General References | - Ron M, Menczel J, Schwartz L, Palti Z, Kidroni G: Vitamin D3 metabolites in amniotic fluid in relation with maternal and fetal sera in term pregnancies. J Perinat Med. 1987;15(3):282-90. [PubMed:3501463 ]
- Imawari M, Kozawa K, Yoshida T, Osuga T: A simple and sensitive assay for 25-hydroxyvitamin D, 24,25-dihydroxyvitamin D and 1,25-dihydroxyvitamin D in human serum. Clin Chim Acta. 1982 Sep 1;124(1):63-73. [PubMed:6982126 ]
- Inaba M, Yukioka K, Furumitsu Y, Murano M, Goto H, Nishizawa Y, Morii H: Positive correlation between levels of IL-1 or IL-2 and 1,25(OH)2D/25-OH-D ratio in synovial fluid of patients with rheumatoid arthritis. Life Sci. 1997;61(10):977-85. [PubMed:9296336 ]
- Traba ML, Babe M, de la Piedra C, Marin A: 24,25-dihydroxyvitamin D3 in serum: sample purification with Sep-Pak C-18 cartridges and liquid chromatography before protein-binding assay. Clin Chem. 1983 Oct;29(10):1806-7. [PubMed:6604593 ]
- Coldwell RD, Trafford DJ, Makin HL, Varley MJ, Kirk DN: Specific estimation of 24,25-dihydroxyvitamin D in plasma by gas chromatography-mass spectrometry. Clin Chem. 1984 Jul;30(7):1193-8. [PubMed:6610503 ]
- Guillemant S, Kremer R: [Radiocompetitive estimation of 25-hydroxyvitamin D in human serum (author's transl)]. Ann Biol Clin (Paris). 1978;36(6):491-6. [PubMed:749564 ]
- Kumar R, Wiesner R, Scott M, Go VL: Physiology of 24,25-dihydroxyvitamin D3 in normal human subjects. Am J Physiol. 1982 Nov;243(5):E370-4. [PubMed:6753604 ]
- Lazebnik R, Eisenberg Z, Lazebnik N, Spirer Z, Weisman Y: Vitamin D metabolites in amniotic fluid. J Clin Endocrinol Metab. 1983 Mar;56(3):632-4. [PubMed:6600461 ]
- Mason RS, Lissner D, Grunstein HS, Posen S: A simplified assay for dihydroxylated vitamin D metabolites in human serum: application to hyper- and hypovitaminosis D. Clin Chem. 1980 Mar;26(3):444-50. [PubMed:6892691 ]
- van Leeuwen JP, van den Bemd GJ, van Driel M, Buurman CJ, Pols HA: 24,25-Dihydroxyvitamin D(3) and bone metabolism. Steroids. 2001 Mar-May;66(3-5):375-80. [PubMed:11179746 ]
|
---|